"Health care leader whose mission is to keep you healthy. Under-one-roof convenience, 24-hour advice nurse, and online access to manage your health anytime. We are here to care for you virtually or in-person. Start by connecting with your care team online (visit our website) or by calling the Appointment and Advice Contact Center at 303-338-4545 or 1-800-218-1059 (TTY 711)."

During the past decade, Kaiser Permanente-Franklin conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 40 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 29 clinical trials were completed. i.e. 193.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente-Franklin" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-Franklin" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-Franklin" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (6 trials), "Recurrent Breast Carcinoma" (5 trials) and "Fallopian Tube Transitional Cell Carcinoma" (4 trials). Many other conditions were trialed in "Kaiser Permanente-Franklin" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-Franklin" are "Drug" (71 trials), "Other" (63 trials), "Biological" (39 trials), "Procedure" (21 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (37 trials), "Quality-of-Life Assessment" (31 trials), "Computed Tomography" (17 trials), "Biospecimen Collection" (16 trials) and "Questionnaire Administration" (16 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-Franklin" are 74 trials for "All" genders, 16 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente-Franklin". undefined are not yet recruiting, 14 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Kaiser Permanente-Franklin, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-Franklin, 0 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".